Szydłowski, R. et al. 2024. PCSK9 inhibitors – new era of dyslipidemia treatment - effectiveness in reducing low-density lipoprotein (LDL-C) and cardiovascular risk. Quality in Sport. 36, (Dec. 2024), 56299. DOI:https://doi.org/10.12775/QS.2024.35.56299.